Top 10 Companies in the Enzymatic (Biocatalytic) Process for Acrylamide Production Market (2026): Market Leaders Powering Global Chemical Production

MARKET INSIGHTS

The Global Enzymatic (Biocatalytic) Process for Acrylamide Production Market size was valued at USD 1.35 billion in 2025. The market is projected to grow from USD 1.45 billion in 2026 to USD 2.65 billion by 2034, exhibiting a CAGR of 7.8% during the forecast period.

The enzymatic or biocatalytic process for acrylamide production involves the use of specialized enzymes, primarily nitrile hydratase, to convert acrylonitrile into acrylamide under mild aqueous conditions. This biocatalytic approach stands in contrast to traditional chemical methods that rely on copper catalysts and higher energy inputs. It enables highly selective hydration while minimizing by‑product formation and energy consumption.

Adoption of this process has accelerated due to its environmental advantages and operational efficiency. While the broader acrylamide market expands with demand from water treatment, enhanced oil recovery, and paper industries, the enzymatic route offers significant sustainability benefits because it operates at lower temperatures and reduces hazardous waste. Furthermore, advancements in enzyme engineering and immobilization techniques have improved catalyst stability and reusability, making large‑scale biocatalytic production increasingly viable for manufacturers seeking greener alternatives. Key industry players continue to invest in optimizing nitrile hydratase‑based systems to meet growing regulatory pressures for cleaner chemical manufacturing processes.

Enzymatic (Biocatalytic) Process for Acrylamide Production Market – View in Detailed Research Report

MARKET DRIVERS

Sustainability and Green Chemistry Initiatives

The enzymatic or biocatalytic process for acrylamide production has gained significant traction due to its alignment with global sustainability goals. Unlike traditional copper‑catalyzed methods that operate under high pressure and temperature, the biocatalytic route using nitrile hydratase enzymes functions under mild conditions, substantially lowering energy consumption and reducing hazardous waste generation.

Growing Demand in Key End‑Use Industries

Rising consumption of polyacrylamide in water treatment, enhanced oil recovery, paper manufacturing, and mining drives the need for high‑purity acrylamide. The biocatalytic process delivers superior selectivity and higher conversion rates, resulting in fewer by‑products such as acrylic acid, which improves downstream polymer performance and supports large‑scale industrial applications.

➤ Biocatalytic production achieves space‑time yields comparable to heterogeneous catalysts while offering easier catalyst separation and minimal by‑product formation.

Furthermore, stringent environmental regulations worldwide encourage manufacturers to transition from chemical synthesis to enzymatic methods, as the latter minimizes environmental footprint and supports corporate sustainability reporting requirements.

MARKET CHALLENGES

High Initial Setup and Operational Costs

Establishing biocatalytic production facilities demands substantial capital investment in enzyme production, immobilization technologies, and specialized bioreactors. While operational energy costs are lower, the upfront expenses and ongoing enzyme sourcing or regeneration can strain smaller producers transitioning from conventional processes.

Other Challenges

Enzyme Stability and Process Optimization
Maintaining consistent enzyme activity over extended production cycles remains technically demanding, as factors such as temperature fluctuations, substrate inhibition, or pH variations can reduce catalyst longevity and overall process efficiency.

Scalability and Supply Chain Integration
Scaling biocatalytic processes to match the massive volumes required by global polyacrylamide markets presents logistical hurdles, including integration with existing chemical infrastructure and ensuring reliable supply of high‑quality biocatalysts.

MARKET RESTRAINTS

Competition from Established Chemical Routes

Traditional chemical synthesis methods for acrylamide remain deeply entrenched due to their mature infrastructure, lower perceived per‑unit costs at very large scales, and widespread industry familiarity. Many facilities continue to favor copper‑based catalysis because of existing capital investments and proven reliability in high‑volume output.

Regulatory complexities surrounding biocatalysts, particularly those involving genetically modified microorganisms or engineered enzymes, add layers of approval processes that can delay market entry or expansion in certain regions. Additionally, raw material price volatility for acrylonitrile feedstock affects both routes but poses disproportionate challenges for newer biocatalytic operations still optimizing yields.

MARKET OPPORTUNITIES

Technological Advancements in Enzyme Engineering

Ongoing innovations in enzyme immobilization, genetic engineering, and bioreactor design present strong potential to enhance biocatalyst stability, recyclability, and productivity. These improvements can further reduce production costs and make enzymatic processes more competitive against traditional methods across diverse geographies.

Expansion into emerging markets with growing water treatment and industrial infrastructure needs offers significant upside, especially where environmental regulations are tightening. Partnerships between enzyme specialists and major chemical manufacturers can accelerate adoption, while the development of food‑grade or higher‑purity biocatalytic acrylamide opens doors to additional specialized applications.

Segment Analysis:

Segment Category	Sub‑Segments	Key Insights
By Type	Free Enzyme Systems Immobilized Enzyme Systems Microbial Whole‑Cell Catalysts Recombinant Engineered Biocatalysts	Immobilized Enzyme Systems represent the leading segment due to their exceptional operational stability, ease of separation from the reaction mixture, and ability to support repeated use in continuous production setups. These systems enable precise control over the hydration of acrylonitrile under mild aqueous conditions, minimizing by‑product formation and energy consumption while delivering high‑purity acrylamide suitable for downstream polymerization. The reusability aspect enhances process economics and aligns with sustainability goals by reducing catalyst replacement frequency. In contrast, free enzyme systems offer rapid initial activity but face challenges in recovery, whereas recombinant variants provide tailored specificity and robustness against industrial stressors such as substrate inhibition.
By Application	Water Treatment Flocculants Paper and Pulp Strengthening Agents Enhanced Oil Recovery Cosmetics and Personal Care Others	Water Treatment Flocculants emerge as the leading segment owing to the critical role of high‑purity polyacrylamide derived from biocatalytically produced acrylamide in effective coagulation and sedimentation processes. The enzymatic route ensures minimal residual impurities and consistent polymer performance, which is essential for meeting stringent regulatory requirements in municipal and industrial wastewater management. This application benefits from the mild reaction conditions that preserve the monomer’s reactivity for superior chain formation in flocculant polymers. Paper and pulp applications follow closely, leveraging the product for improved sheet strength and retention, while enhanced oil recovery utilizes the viscosity‑modifying properties in demanding reservoir conditions. The biocatalytic advantage lies in delivering a cleaner monomer profile that translates to more reliable polymer behavior across these diverse uses.
By End User	Chemical Manufacturers Water and Wastewater Utilities Oil and Gas Companies Paper and Pulp Producers	Water and Wastewater Utilities stand out as the leading end user segment, capitalizing on the environmental compatibility and consistent quality of enzymatically produced acrylamide for large‑scale flocculant production. These utilities prioritize sustainable sourcing to comply with evolving environmental standards, where the biocatalytic process offers reduced energy input, lower waste generation, and avoidance of heavy metal contaminants associated with traditional methods. The resulting polyacrylamide exhibits excellent flocculation efficiency, supporting effective contaminant removal in both potable water and effluent treatment. Chemical manufacturers benefit from integrating this green monomer into their value chains for downstream derivatives, while oil and gas operators value the reliability in polymer flooding applications under harsh field conditions. Overall, the shift toward biocatalysis supports broader corporate sustainability initiatives across these industries.
By Production Process	Batch Process Continuous Process Fed‑Batch Hybrid Systems	Continuous Process leads this segment by enabling seamless integration of immobilized biocatalysts into flow systems, achieving superior productivity and consistent product quality with minimal downtime. The enzymatic hydration proceeds efficiently at ambient temperatures and neutral pH, facilitating real‑time monitoring and adjustment of parameters such as substrate feed rates to optimize conversion while preventing enzyme deactivation. This approach reduces operational footprint compared to batch methods and supports scalable manufacturing aligned with fluctuating demand from end‑use sectors. Fed‑batch hybrids provide flexibility for sensitive catalyst formulations, but continuous systems excel in delivering the high‑volume, uniform acrylamide required for industrial polymerization, reinforcing the overall sustainability and cost‑effectiveness of the biocatalytic pathway.
By Catalyst Source	Nitrile Hydratase from Rhodococcus Species Genetically Optimized Microbial Strains Recombinant Expression Systems	Nitrile Hydratase from Rhodococcus Species dominates as the leading catalyst source, prized for its inherent high activity, selectivity, and robustness in converting acrylonitrile to acrylamide under industrial conditions. These microbial‑derived enzymes operate with remarkable efficiency, tolerating elevated substrate concentrations while maintaining stereospecificity and minimizing side reactions that could compromise product purity. Advances in strain improvement and immobilization techniques further enhance their longevity and performance, making them the preferred choice for commercial‑scale operations. Recombinant systems allow fine‑tuning of enzyme properties for specific process demands, such as enhanced thermal stability, yet the natural Rhodococcus variants provide a proven, reliable foundation that underpins the widespread adoption of biocatalytic acrylamide production. This biological precision supports cleaner manufacturing and facilitates compliance with green chemistry principles across global supply chains.

COMPETITIVE LANDSCAPE

Key Industry Players

The Enzymatic (Biocatalytic) Process for Acrylamide Production Market features established chemical giants leveraging nitrile hydratase‑based biocatalysis for sustainable, high‑yield monomer manufacturing.

The enzymatic (biocatalytic) process for acrylamide production has become the dominant industrial route worldwide, replacing traditional copper‑catalyzed hydration due to its milder operating conditions, higher selectivity, and reduced environmental impact. Leading players such as BASF SE and Mitsui Chemicals have heavily invested in this technology, operating dedicated BioACM plants with capacities exceeding 50,000 tons per year in key regions including Europe, North America, and Asia. These companies utilize immobilized microbial cells or isolated nitrile hydratase enzymes derived primarily from Rhodococcus species to convert acrylonitrile to acrylamide with yields often surpassing 99%. The market structure is moderately consolidated among large specialty chemical manufacturers that integrate biocatalytic acrylamide production with downstream polyacrylamide applications for water treatment, enhanced oil recovery, and paper industries. Operational facilities remain active, with no major recent mergers directly impacting core biocatalytic acrylamide assets, though broader corporate consolidations in the enzyme space continue. Most profiled entities function as integrated manufacturers rather than pure distributors.

Emerging and niche participants focus on enzyme optimization, novel microbial strains, and regional production to support growing demand for green chemistry solutions. While enzyme specialists like Novozymes (now part of Novonesis) and DSM‑Firmenich primarily supply biocatalysts for various industrial applications, their technologies indirectly support acrylamide processes. Smaller or specialized firms explore advanced immobilization techniques and strain engineering but hold limited commercial‑scale production shares compared to the vertically integrated majors. The competitive dynamics emphasize continuous improvement in catalyst stability, process efficiency, and sustainability metrics to meet stringent regulatory and customer requirements across global supply chains.

BASF SE (Germany)
Mitsui Chemicals, Inc. (Japan)
Mitsubishi Chemical Corporation (Japan)
Kemira Oyj (Finland)
SNF Group (France)
Dia‑Nitrix Co., Ltd. (Japan)
Ashland Global Holdings Inc. (United States)
Nippon Shokubai Co., Ltd. (Japan)
Beijing Hengju Chemical Group Corporation (China)
AnHui JuCheng Fine Chemicals Co., Ltd. (China)

Top 10 Companies in the Enzymatic (Biocatalytic) Process for Acrylamide Production Market (2026)

🔟 1. BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: BioACM plant, high‑purity acrylamide, polyacrylamide solutions for water treatment, oil recovery, and paper.

BASF SE has established a world‑class biocatalytic facility in Nanjing with a capacity of 50,000 t / yr, delivering >99% yield acrylamide. The plant integrates advanced immobilized nitrile hydratase and real‑time process control, enabling continuous operation and low energy consumption.